Get the Stockscreener App
89.79
1.09%
-0.99
After Hours:
89.79
Ani Pharmaceuticals Inc stock is traded at $89.79, with a volume of 173.71K.
It is down -1.09% in the last 24 hours and down -7.87% over the past month.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
See More
Previous Close:
$90.78
Open:
$91.05
24h Volume:
173.71K
Relative Volume:
0.38
Market Cap:
$1.95B
Revenue:
$486.82M
Net Income/Loss:
$18.78M
P/E Ratio:
109.50
EPS:
0.82
Net Cash Flow:
$100.45M
1W Performance:
+0.17%
1M Performance:
-7.87%
6M Performance:
+37.88%
1Y Performance:
+62.96%
1-Day Range:
$89.31
$91.47
1-Week Range:
$89.13
$92.56
52-Week Range:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Name
Ani Pharmaceuticals Inc
Sector
Phone
(218) 634-3500
Address
210 MAIN STREET WEST, BAUDETTE, MN
Compare ANIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
89.79 | 2.02B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Initiated | H.C. Wainwright | Buy |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Mar-12-25 | Initiated | JP Morgan | Overweight |
| Dec-11-24 | Initiated | Leerink Partners | Outperform |
| Oct-11-24 | Initiated | Piper Sandler | Overweight |
| Mar-15-24 | Initiated | CapitalOne | Overweight |
| Aug-22-23 | Reiterated | H.C. Wainwright | Buy |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Sep-07-22 | Initiated | H.C. Wainwright | Buy |
| Nov-02-21 | Initiated | Truist | Buy |
| May-07-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| May-10-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-16-17 | Reiterated | Canaccord Genuity | Buy |
| Jul-31-17 | Initiated | Canaccord Genuity | Buy |
| Feb-22-17 | Downgrade | ROTH Capital | Buy → Neutral |
| Jun-23-16 | Initiated | Raymond James | Strong Buy |
| May-24-16 | Downgrade | Standpoint Research | Buy → Hold |
| Nov-13-15 | Initiated | Standpoint Research | Buy |
| Sep-28-15 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-05-15 | Reiterated | Oppenheimer | Outperform |
| Aug-04-15 | Reiterated | ROTH Capital | Neutral |
| Jul-31-15 | Reiterated | Oppenheimer | Outperform |
| Jul-15-15 | Reiterated | ROTH Capital | Neutral |
| Jun-23-15 | Reiterated | Oppenheimer | Outperform |
| May-18-15 | Reiterated | ROTH Capital | Neutral |
| May-06-15 | Reiterated | Oppenheimer | Outperform |
| Apr-10-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-26-15 | Reiterated | ROTH Capital | Buy |
| Feb-18-15 | Reiterated | Oppenheimer | Outperform |
View All
Ani Pharmaceuticals Inc Stock (ANIP) Latest News
Is ANI Pharmaceuticals Inc. a candidate for recovery play2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat
Visualizing ANI Pharmaceuticals Inc. stock with heatmaps2025 Price Targets & Weekly High Momentum Picks - newser.com
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
ANI Pharmaceuticals Inc. stock trend forecastTrade Signal Summary & Daily Technical Forecast Reports - newser.com
What recovery options are there for ANI Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Will a bounce in ANI Pharmaceuticals Inc. offer an exitQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
How ANI Pharmaceuticals Inc. (BSFA) stock compares with tech leaders2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Analyzing recovery setups for ANI Pharmaceuticals Inc. investors2025 Year in Review & Technical Confirmation Trade Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock beat value stocksQuarterly Profit Report & Pattern Based Trade Signal System - newser.com
Is ANI Pharmaceuticals Inc. stock undervalued vs historical averages2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat
ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail
Can ANI Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Technical Patterns & Risk Managed Investment Signals - newser.com
Institutional scanner results for ANI Pharmaceuticals Inc.Bond Market & Low Drawdown Trading Strategies - newser.com
Can ANI Pharmaceuticals Inc. stock sustain revenue growth2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Live market analysis of ANI Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is a relief rally coming for ANI Pharmaceuticals Inc. holdersWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
What moving averages say about ANI Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - newser.com
A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation as Quiet Market Moves Draw Investor Interest - Yahoo Finance
What analysts say about ANI Pharmaceuticals Inc stockLong-Term Investment Plans & Swing Trade Smarter With Data Insights - earlytimes.in
Assenagon Asset Management S.A. Sells 101,728 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals Inc Stock (ANIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ani Pharmaceuticals Inc Stock (ANIP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. |
Sep 12 '25 |
Sale |
98.42 |
400 |
39,368 |
76,074 |
| Pera Antonio R | Director |
Sep 03 '25 |
Sale |
94.94 |
7,292 |
692,302 |
22,660 |
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):